New Modalities of Cell Therapies: Revolutionizing the Way We Treat Diseases Chair: Aya Jakobovits, PhD Deep Diving: The Role of Artificial Intelligence in Medicine Chairs: Allen Kamer, Managing Partner, OurCrowd Qure; Anat Naschitz, Managing Director, OrbiMed Advisors
Disruptive and Advanced Medical Devices Chairs: Irit Yaniv, MD, General Partner, Accelmed; Ron Ginor, MD, Venture Partner, OrbiMed Advisors, L.L.C
| Prevention and Rehabilitation: Should the Underdog Begin Barking? Chair: Naomi Gefen, Deputy Director General, ALYN Hospital Tango of the Two: Academia and Industry Chair: Prof. Yael Hanein, PhD, School of Electrical Engineering, Tel Aviv University
Gene Editing and Gene Therapy: The Next Frontier in Human Health Chairs: Yael Weiss, MD, PhD, Vice President Business Development, Ultragenyx; Stephen Squinto, PhD, Venture Partner of OrbiMed Advisors, L.L.C | Transformative Cancer TherapiesChair: Prof. David Sidransky, MD, Johns Hopkins School of Medicine; Co-Founder and General Partner, Israel Biotech Fund Personalized Medicine and Digital Health: Lessons Learned and Challenges Ahead Chairs: Yair Schindel, MD, Co-Founder & Managing Director, aMoon; Prof. Varda Shalev, MD, MPA, Managing Director, Morris Kahn & Maccabi Research & Innovation Institute at Maccabi Health Care Services
Cannabis’ Therapeutic Promise: Hope or Hype? Chair: TBA
|